Sinead M Walsh
Overview
Explore the profile of Sinead M Walsh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walsh S, Forward C, Flaherty G
J Sleep Res
. 2022 Jun;
31(6):e13672.
PMID: 35726362
Parasomnias are undesirable events that occur during sleep. They can be classified into rapid eye movement parasomnias and non-rapid eye movement parasomnias. Those who experience parasomnias may be anxious about...
2.
Walsh S, Costello M, Murphy E, Lowery A, McDermott B, Byrne D
BMJ Simul Technol Enhanc Learn
. 2022 May;
7(5):452-453.
PMID: 35515715
The letter provides practical tips for developing, implementing and scaling an effective simulation‑based education programme at a large scale for undergraduate medical students. Using time-lapsed scenarios and the pause-discuss method...
3.
Costello M, Cantillon P, Geoghegan R, Byrne D, Lowery A, Walsh S
Clin Teach
. 2021 Nov;
19(1):42-47.
PMID: 34841664
Background: Clinical education represents the most important formative period in undergraduate medical education. It is often criticised as haphazard and inefficient. Experience-based learning (ExBL) is a novel clinical education design...
4.
Worrell J, Walsh S, Fabre A, Kane R, Hinz B, Keane M
Am J Physiol Cell Physiol
. 2020 Oct;
319(6):C1059-C1069.
PMID: 33026833
CXC chemokine receptor 3 (CXCR3) A and its IFN-inducible ligands CXCL9 and CXCL10 regulate vascular remodeling and fibroblast motility. IL-13 is a profibrotic cytokine implicated in the pathogenesis of inflammatory...
5.
6.
Walsh S, Worrell J, Fabre A, Hinz B, Kane R, Keane M
Am J Physiol Lung Cell Mol Physiol
. 2018 Aug;
315(5):L697-L710.
PMID: 30091381
Idiopathic pulmonary fibrosis (IPF), a chronic progressive interstitial pneumonia, is characterized by excessive fibroproliferation. Key effector cells in IPF are myofibroblasts that are recruited from three potential sources: resident fibroblasts,...
7.
8.
Murphy N, Gaynor K, Rowan S, Walsh S, Fabre A, Boylan J, et al.
Am J Pathol
. 2016 Jan;
186(3):600-15.
PMID: 26765958
Idiopathic pulmonary fibrosis is a chronic, progressive fibrotic disease with a poor prognosis. The balance between transforming growth factor β1 and bone morphogenetic protein (BMP) signaling plays an important role...
9.
OBeirne S, Walsh S, Fabre A, Reviriego C, Worrell J, Counihan I, et al.
J Immunol
. 2015 Aug;
195(6):2788-96.
PMID: 26268659
Epithelial to mesenchymal cell transition (EMT), whereby fully differentiated epithelial cells transition to a mesenchymal phenotype, has been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF). CXCR3 and its...
10.
Lumsden R, Worrell J, Boylan D, Walsh S, Cramton J, Counihan I, et al.
Am J Physiol Lung Cell Mol Physiol
. 2015 Feb;
308(7):L710-8.
PMID: 25659898
Pulmonary fibrosis is a progressive and fatal disease that involves the remodeling of the distal airspace and the lung parenchyma, which results in compromised gas exchange. The median survival time...